These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27106606)

  • 1. Enhancing glioblastoma cell sensitivity to chemotherapeutics: A strategy involving survivin gene silencing mediated by gemini surfactant-based complexes.
    Cruz RQ; Morais CM; Cardoso AM; Silva SG; Vale ML; Marques EF; Pedroso de Lima MC; Jurado AS
    Eur J Pharm Biopharm; 2016 Jul; 104():7-18. PubMed ID: 27106606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.
    Kumar K; Maiti B; Kondaiah P; Bhattacharya S
    Mol Pharm; 2015 Feb; 12(2):351-61. PubMed ID: 25438085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin.
    Lee DH; Lee CS; Kim DW; Ae JE; Lee TH
    Anticancer Drugs; 2014 Jan; 25(1):44-52. PubMed ID: 24045365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
    Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.
    Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S
    Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents.
    Trabulo S; Cardoso AM; Santos-Ferreira T; Cardoso AL; Simões S; Pedroso de Lima MC
    Mol Pharm; 2011 Aug; 8(4):1120-31. PubMed ID: 21619051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Src enhances the cytotoxic effect of temozolomide through AKT in glioma.
    Wang Z; Sun J; Li X; Yang S; Yue S; Zhang J; Yang X; Zhu T; Jiang R; Yang W
    Oncol Rep; 2013 Apr; 29(4):1395-8. PubMed ID: 23338526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.
    Wang F; Bhat K; Doucette M; Zhou S; Gu Y; Law B; Liu X; Wong ET; Kang JX; Hsieh TC; Qian SY; Wu E
    Curr Mol Med; 2011 Aug; 11(6):503-11. PubMed ID: 21663587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines.
    Elhag R; Mazzio EA; Soliman KF
    Anticancer Res; 2015 Mar; 35(3):1263-9. PubMed ID: 25750273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo.
    Hendruschk S; Wiedemuth R; Aigner A; Töpfer K; Cartellieri M; Martin D; Kirsch M; Ikonomidou C; Schackert G; Temme A
    Neuro Oncol; 2011 Oct; 13(10):1074-89. PubMed ID: 21788344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
    Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
    Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines.
    Balça-Silva J; Matias D; do Carmo A; Girão H; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC
    Biochim Biophys Acta; 2015 Apr; 1850(4):722-32. PubMed ID: 25554223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
    Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells
    Suzuki S; Kitanaka C; Okada M
    Anticancer Res; 2024 Sep; 44(9):3875-3883. PubMed ID: 39197897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP; Godoy PR; Sakamoto-Hojo ET
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-224 expression increases radiation sensitivity of glioblastoma cells.
    Upraity S; Kazi S; Padul V; Shirsat NV
    Biochem Biophys Res Commun; 2014 May; 448(2):225-30. PubMed ID: 24785373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
    Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
    Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.